Vera Therapeutics Inc - Class A

Research Vera Therapeutics Inc - Class A (VERA) on Bullrun: market cap USD 3.10B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVERA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.10B
• Financial periodFY2025
• Net income-USD 299.62M
• Free cash flow-USD 241.73M

Valuation Snapshot

latest market cap is USD 3.10B.

About Vera Therapeutics Inc - Class A

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases.

Frequently asked questions

What is Vera Therapeutics Inc - Class A's market cap?

Vera Therapeutics Inc - Class A's market capitalization is USD 3.10B.

What does Vera Therapeutics Inc - Class A do?

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.